Delivery Order SPE2DB22D3016-SPE2DB25FAPY3

Award Date 3/3/25
Potential Completion Date 3/4/25
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, SPE2DB20D1100|SPE2DB25FZ39T, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,446.54 firm fixed-price delivery order is for ANNOVERA vaginal rings. The contract has an ultimate completion date of December 6, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,506.26, is for the delivery of ANNOVERA vaginal rings. It is a firm fixed-price delivery order contract with a completion date of January 23, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with an award value of $2,618.79, is a Delivery Order for the procurement of ANNOVERA Vaginal Rings. The contract has an ultimate completion date of December 11, 2024 and is a Firm Fixed Price contract type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,731.14, is for the delivery of ANNOVERA vaginal rings to fulfill the agency's medical supply requirements. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of January 6, 2025. This award is not associated with a set-aside designation, indicating...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,824.77 Firm Fixed Price Delivery Order contract is for the supply of ANNOVERA vaginal rings. The contract has an ultimate completion date of January 23, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,521.44 firm fixed-price delivery order contract is for the supply of ANNOVERA vaginal rings, a contraceptive product. The contract has an ultimate completion date of December 12, 2024 and was awarded on December 11, 2024. This award is part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,709.21 with a completion date of February 21, 2025. The contract is for the supply of ANNOVERA vaginal rings and was awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has a firm fixed price pricing type and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,334.16 Firm Fixed Price delivery order is for the supply of ANNOVERA vaginal rings, with a performance period through February 8, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,773.82 firm fixed-price delivery order is for the supply of ANNOVERA vaginal rings, with a completion date of November 23, 2022. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award, valued at $1,197.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DX15D3007|SPE2DX24F9M0Q) for the supply of ANNOVERA vaginal rings. The contract has an ultimate completion date of May 22, 2024 and is a firm fixed-price arrangement. The contract is not designated as a set-aside. Amerisourcebergen holds a larger $999,999,999...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAPY3
    Delivery Order

The federal contract award SPE2DB22D3016|SPE2DB25FAPY3 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,079.76 firm-fixed-price delivery order is for the procurement of ANNOVERA Vaginal Rings. The contract has an ultimate completion date of March 4, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award was not designated with a set-aside requirement, indicating open competition.

Generated 6/2/25, 9:55 AM